Literature DB >> 25285802

Haploidentical hematopoietic SCT for acquired severe aplastic anemia using post-transplant high-dose CY.

N Gupta1, D Choudhary1, S K Sharma1, V Khandelwal1, M Dhamija1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25285802     DOI： 10.1038/bmt.2014.222

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  10 in total

1.  Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning.

Authors:  Kavita Raj; Antonio Pagliuca; Kenneth Bradstock; Victor Noriega; Victoria Potter; Matthew Streetly; Donal McLornan; Majid Kazmi; Judith Marsh; John Kwan; Gillian Huang; Lisa Getzendaner; Stephanie Lee; Katherine A Guthrie; Ghulam J Mufti; Paul O'Donnell
Journal:  Biol Blood Marrow Transplant       Date:  2014-03-18       Impact factor: 5.742

Review 2.  Management of the refractory aplastic anemia patient: what are the options?

Authors:  Judith C W Marsh; Austin G Kulasekararaj
Journal:  Blood       Date:  2013-09-19       Impact factor: 22.113

Review 3.  Haploidentical transplantation in patients with acquired aplastic anemia.

Authors:  F Ciceri; M T Lupo-Stanghellini; E T Korthof
Journal:  Bone Marrow Transplant       Date:  2013-01-07       Impact factor: 5.483

4.  Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party.

Authors:  Andrea Bacigalupo; Gerard Socie'; Edoardo Lanino; Arcangelo Prete; Franco Locatelli; Anna Locasciulli; Simone Cesaro; Avichai Shimoni; Judith Marsh; Mats Brune; Maria Teresa Van Lint; Rosi Oneto; Jacob Passweg
Journal:  Haematologica       Date:  2010-05-21       Impact factor: 9.941

5.  HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

Authors:  Leo Luznik; Paul V O'Donnell; Heather J Symons; Allen R Chen; M Susan Leffell; Marianna Zahurak; Ted A Gooley; Steve Piantadosi; Michele Kaup; Richard F Ambinder; Carol Ann Huff; William Matsui; Javier Bolaños-Meade; Ivan Borrello; Jonathan D Powell; Elizabeth Harrington; Sandy Warnock; Mary Flowers; Robert A Brodsky; Brenda M Sandmaier; Rainer F Storb; Richard J Jones; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2008-06       Impact factor: 5.742

Review 6.  Acquired aplastic anemia in childhood.

Authors:  Eva C Guinan
Journal:  Hematol Oncol Clin North Am       Date:  2009-04       Impact factor: 3.722

7.  Unrelated cord blood transplantation for severe aplastic anemia.

Authors:  Ayami Yoshimi; Seiji Kojima; Shuichi Taniguchi; Junichi Hara; Toshimitsu Matsui; Yoshiyuki Takahashi; Hiroshi Azuma; Koji Kato; Tokiko Nagamura-Inoue; Shunro Kai; Shunichi Kato
Journal:  Biol Blood Marrow Transplant       Date:  2008-09       Impact factor: 5.742

8.  Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide.

Authors:  Luca Castagna; Roberto Crocchiolo; Sabine Furst; Stefania Bramanti; Jean El Cheikh; Barbara Sarina; Angela Granata; Elisa Mauro; Catherine Faucher; Bilal Mohty; Samia Harbi; Christian Chabannon; Carmelo Carlo-Stella; Armando Santoro; Didier Blaise
Journal:  Biol Blood Marrow Transplant       Date:  2014-02-13       Impact factor: 5.742

9.  HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease.

Authors:  Javier Bolaños-Meade; Ephraim J Fuchs; Leo Luznik; Sophie M Lanzkron; Christopher J Gamper; Richard J Jones; Robert A Brodsky
Journal:  Blood       Date:  2012-09-06       Impact factor: 22.113

Review 10.  Human leukocyte antigen-haploidentical stem cell transplantation using T-cell-replete bone marrow grafts.

Authors:  Ephraim J Fuchs
Journal:  Curr Opin Hematol       Date:  2012-11       Impact factor: 3.284
  10 in total
  5 in total

1.  Unmanipulated haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide in a patient with paroxysmal nocturnal hemoglobinuria and secondary aplastic anemia.

Authors:  M Sarmiento; P A Ramírez
Journal:  Bone Marrow Transplant       Date:  2015-10-26       Impact factor: 5.483

Review 2.  Evolving hematopoietic stem cell transplantation strategies in severe aplastic anemia.

Authors:  Andrew C Dietz; Giovanna Lucchini; Sujith Samarasinghe; Michael A Pulsipher
Journal:  Curr Opin Pediatr       Date:  2016-02       Impact factor: 2.856

3.  Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study.

Authors:  I Esteves; C Bonfim; R Pasquini; V Funke; N F Pereira; V Rocha; Y Novis; C Arrais; V Colturato; M P de Souza; M Torres; J F Fernandes; F R Kerbauy; A A F Ribeiro; F P S Santos; N Hamerschlak
Journal:  Bone Marrow Transplant       Date:  2015-03-02       Impact factor: 5.483

Review 4.  Haploidentical Donor Bone Marrow Transplantation for Severe Aplastic Anemia.

Authors:  Amy E DeZern; Robert A Brodsky
Journal:  Hematol Oncol Clin North Am       Date:  2018-05-28       Impact factor: 3.722

5.  Clinical evaluation of haploidentical hematopoietic combined with human umbilical cord-derived mesenchymal stem cells in severe aplastic anemia.

Authors:  Lixin Xu; Zhouyang Liu; Yamei Wu; Xueliang Yang; Yongbin Cao; Xiaohong Li; Bei Yan; Songwei Li; Wanming Da; Xiaoxiong Wu
Journal:  Eur J Med Res       Date:  2018-03-01       Impact factor: 2.175
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.